| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.091 | 0.002 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.094 | 0.003 |